dalteparin has been researched along with Pneumonia, Viral in 35 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 71-year old gentleman with history of arterial hypertension treated with valsartan presented on was hospitalized at the Infectious Diseases Unit, University of Bologna (Italy) for severe acute respiratory syndrome- coronavirus-2 (SARS-CoV-2) and received treatment with hydroxychloroquine 200mg bid (400 mg bid the first day), azithromycin 400 mg qd, thrombotic prophylaxis with enoxaparin 4000 UI qd and Venturi mask oxygen delivering FiO2 of 31%." | 3.96 | Clinical experience with therapeutic dose of Low-Molecular-Weight Heparin. ( Bartoletti, M; Viale, P, 2020) |
| "We report a case of ophthalmic artery occlusion (OAO) in a young patient with COVID-19 infection that was on therapeutic anticoagulation with apixaban for deep venous thrombosis (DVT)." | 3.96 | Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban. ( Biousse, V; Bose, S; Dumitrascu, OM; Lyden, PD; Volod, O; Wang, Y, 2020) |
| " The aim of our study was to evaluate the clinical impact of venous thromboembolism prophylaxis with fondaparinux versus enoxaparin among 100 hospitalized COVID-19 patients." | 3.96 | Fondaparinux Use in Patients With COVID-19: A Preliminary Multicenter Real-World Experience. ( Agrusta, F; Amitrano, M; Bellizzi, A; Cardillo, G; Cavalli, A; Di Micco, P; Fontanella, A; Iannuzzo, M; Lodigiani, C; Mangiacapra, S; Russo, V; Sacco, C; Viggiano, GV, 2020) |
| "A 61-year old patient with ankylosing spondylitis who was on secukinumab therapy for 5 months admitted with newly onset fever and gastrointestinal complaints." | 2.66 | Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review. ( Coskun Benlidayi, I; Guzel, R; Kurtaran, B; Tirasci, E, 2020) |
| "Acute pulmonary embolism and coronavirus disease were diagnosed." | 1.56 | COVID-19 and Acute Pulmonary Embolism in Postpartum Patient. ( Boogar, SS; Khodamoradi, Z; Kouhi, P; Shirazi, FKH, 2020) |
| " An antithrombotic prophylaxis at low dosage was immediately started, then increased at prophylactic dosage." | 1.56 | How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report. ( Campello, E; Pasca, S; Simioni, P; Spiezia, L; Vettor, R; Zanon, E, 2020) |
| "Key words: Coronavirus disease 2019 (COVID-19), Meningoencephalitis, Pneumonia." | 1.56 | A Case of 45-Year Man Who Succumbed to Coronavirus Disease 2019 (COVID-19). ( Khan, MA, 2020) |
| "A chest CT scan showed an acute type B aortic dissection (ATBAD) and bilateral lung involvement with ground-glass opacity, compatible with interstitial pneumonia." | 1.56 | An infection-oriented approach for thoracic endovascular aortic repair in a SARS-CoV-2 positive patient. A case report. ( Ferrari, SA; Muzzarelli, L; Piconi, S; Rossi, G; Sommaruga, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 35 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brüggemann, R | 1 |
| Gietema, H | 1 |
| Jallah, B | 1 |
| Ten Cate, H | 1 |
| Stehouwer, C | 1 |
| Spaetgens, B | 1 |
| Lozano, R | 1 |
| Franco, ME | 1 |
| Griffin, DO | 1 |
| Jensen, A | 1 |
| Khan, M | 1 |
| Chin, J | 1 |
| Chin, K | 1 |
| Saad, J | 1 |
| Parnell, R | 1 |
| Awwad, C | 1 |
| Patel, D | 1 |
| Khodamoradi, Z | 1 |
| Boogar, SS | 1 |
| Shirazi, FKH | 1 |
| Kouhi, P | 1 |
| Artifoni, M | 1 |
| Danic, G | 1 |
| Gautier, G | 1 |
| Gicquel, P | 1 |
| Boutoille, D | 1 |
| Raffi, F | 1 |
| Néel, A | 1 |
| Lecomte, R | 1 |
| Cattaneo, M | 1 |
| Morici, N | 1 |
| Marietta, M | 1 |
| Tripodi, A | 1 |
| Alay, H | 1 |
| Can, FK | 1 |
| Gözgeç, E | 1 |
| Akel, T | 1 |
| Qaqa, F | 1 |
| Abuarqoub, A | 1 |
| Shamoon, F | 1 |
| Viale, P | 1 |
| Bartoletti, M | 1 |
| Valente-Acosta, B | 1 |
| Moreno-Sanchez, F | 1 |
| Fueyo-Rodriguez, O | 1 |
| Palomar-Lever, A | 1 |
| Coskun Benlidayi, I | 1 |
| Kurtaran, B | 1 |
| Tirasci, E | 1 |
| Guzel, R | 1 |
| Sierra-Hidalgo, F | 1 |
| Muñoz-Rivas, N | 1 |
| Torres Rubio, P | 1 |
| Chao, K | 1 |
| Villanova Martínez, M | 1 |
| Arranz García, P | 1 |
| Martínez-Acebes, E | 1 |
| La Mura, V | 1 |
| Artoni, A | 1 |
| Martinelli, I | 1 |
| Rossio, R | 1 |
| Gualtierotti, R | 1 |
| Ghigliazza, G | 1 |
| Fusco, S | 1 |
| Ierardi, AM | 1 |
| Andrisani, MC | 1 |
| Carrafiello, G | 1 |
| Peyvandi, F | 1 |
| Massabeti, R | 1 |
| Cipriani, MS | 1 |
| Valenti, I | 1 |
| Zanon, E | 1 |
| Pasca, S | 1 |
| Campello, E | 1 |
| Spiezia, L | 1 |
| Vettor, R | 1 |
| Simioni, P | 1 |
| Dumitrascu, OM | 1 |
| Volod, O | 1 |
| Bose, S | 1 |
| Wang, Y | 1 |
| Biousse, V | 1 |
| Lyden, PD | 1 |
| Trimaille, A | 1 |
| Curtiaud, A | 1 |
| Marchandot, B | 1 |
| Matsushita, K | 1 |
| Sato, C | 1 |
| Leonard-Lorant, I | 1 |
| Sattler, L | 1 |
| Grunebaum, L | 1 |
| Ohana, M | 1 |
| Von Hunolstein, JJ | 1 |
| Andres, E | 1 |
| Goichot, B | 1 |
| Danion, F | 1 |
| Kaeuffer, C | 1 |
| Poindron, V | 1 |
| Ohlmann, P | 1 |
| Jesel, L | 1 |
| Morel, O | 1 |
| Moll, M | 1 |
| Zon, RL | 1 |
| Sylvester, KW | 1 |
| Chen, EC | 1 |
| Cheng, V | 1 |
| Connell, NT | 1 |
| Fredenburgh, LE | 1 |
| Baron, RM | 1 |
| Cho, MH | 1 |
| Woolley, AE | 1 |
| Connors, JM | 1 |
| Abrams, RMC | 1 |
| Kim, BD | 1 |
| Markantone, DM | 1 |
| Reilly, K | 1 |
| Paniz-Mondolfi, AE | 1 |
| Gitman, MR | 1 |
| Choo, SY | 1 |
| Tse, W | 1 |
| Robinson-Papp, J | 1 |
| Khan, MA | 2 |
| Gurkan, O | 1 |
| Yilmaz, A | 1 |
| Cengel, F | 1 |
| Altunok, ES | 1 |
| Ekin, EE | 1 |
| Lal, S | 1 |
| Hashmi, J | 1 |
| Whittemore, P | 1 |
| Macfarlane, L | 1 |
| Herbert, A | 1 |
| Farrant, J | 1 |
| Ferguson, K | 1 |
| Quail, N | 1 |
| Kewin, P | 1 |
| Blyth, KG | 1 |
| Kewan, T | 1 |
| Almhana, F | 1 |
| Schwartzman, L | 1 |
| Daw, H | 1 |
| Haddad, A | 1 |
| Rossi, G | 1 |
| Ferrari, SA | 1 |
| Sommaruga, S | 1 |
| Muzzarelli, L | 1 |
| Piconi, S | 1 |
| Barco, S | 1 |
| Bingisser, R | 1 |
| Colucci, G | 1 |
| Frenk, A | 1 |
| Gerber, B | 1 |
| Held, U | 1 |
| Mach, F | 1 |
| Mazzolai, L | 1 |
| Righini, M | 1 |
| Rosemann, T | 1 |
| Sebastian, T | 1 |
| Spescha, R | 1 |
| Stortecky, S | 1 |
| Windecker, S | 1 |
| Kucher, N | 1 |
| Carmo Filho, A | 1 |
| Cunha, BDS | 1 |
| Russo, V | 1 |
| Cardillo, G | 1 |
| Viggiano, GV | 1 |
| Mangiacapra, S | 1 |
| Cavalli, A | 1 |
| Fontanella, A | 1 |
| Agrusta, F | 1 |
| Bellizzi, A | 1 |
| Amitrano, M | 1 |
| Iannuzzo, M | 1 |
| Sacco, C | 1 |
| Lodigiani, C | 1 |
| Di Micco, P | 1 |
| Bhatt, H | 1 |
| Singh, S | 1 |
| Weingarten, M | 2 |
| Abittan, B | 1 |
| Rivera-Oyola, R | 1 |
| Abittan, AI | 1 |
| Lebwohl, M | 1 |
| Chérrez-Ojeda, I | 1 |
| Vanegas, E | 1 |
| Felix, M | 1 |
| Escher, R | 1 |
| Breakey, N | 1 |
| Lämmle, B | 1 |
| Desborough, MJR | 1 |
| Doyle, AJ | 1 |
| Griffiths, A | 1 |
| Retter, A | 1 |
| Breen, KA | 1 |
| Hunt, BJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Role of Ischemia Modified Albumin in Patients With COVID-19[NCT05286268] | 194 participants (Anticipated) | Observational | 2022-04-06 | Recruiting | |||
| Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With Coronavirus: The Multicenter Randomized Controlled Ovid Trial[NCT04400799] | Phase 3 | 475 participants (Actual) | Interventional | 2020-06-15 | Terminated (stopped due to due to results from interim analysis) | ||
| Early Thromboprophylaxis in COVID-19 (ETHIC Trial): an Open Label, Randomized Phase IIIb Trial of Community-based (LMWH) Versus Standard of Care (no Enoxaparin) in COVID-19 Positive Patients[NCT04492254] | Phase 3 | 219 participants (Actual) | Interventional | 2020-10-27 | Terminated (stopped due to Average event rate (end point) was much lower than expected. A larger sample size would have been required to maintain same statistical power, which was not achievable in a feasible time scale. No safety concerns were identified with bleeding.) | ||
| Dynamics of Hemostatic Parameters in COVID-19 and Comparison of Intervention Strategies Through Adaptive Clinical Trial[NCT04466670] | Phase 2 | 379 participants (Anticipated) | Interventional | 2020-07-11 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for dalteparin and Pneumonia, Viral
| Article | Year |
|---|---|
Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.
Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antirheumatic Agents; Betacoronavirus; Coronaviru | 2020 |
1 trial available for dalteparin and Pneumonia, Viral
| Article | Year |
|---|---|
Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
Topics: Anticoagulants; Betacoronavirus; Blood Coagulation; Coronavirus Infections; COVID-19; Enoxaparin; Eq | 2020 |
33 other studies available for dalteparin and Pneumonia, Viral
| Article | Year |
|---|---|
Arterial and venous thromboembolic disease in a patient with COVID-19: A case report.
Topics: Anticoagulants; Cerebral Infarction; Clopidogrel; Computed Tomography Angiography; Coronavirus Infec | 2020 |
[Incidence of heparin-induced thrombocytopenia in patients with 2019 coronavirus disease].
Topics: Aged; Aged, 80 and over; Anticoagulants; Betacoronavirus; Coronavirus Infections; COVID-19; Female; | 2020 |
Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.
Topics: Acute Disease; Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Betacoronavirus; Biomarkers; | 2020 |
COVID-19 and Acute Pulmonary Embolism in Postpartum Patient.
Topics: Acute Disease; Adult; Anticoagulants; Betacoronavirus; Cesarean Section; Clinical Laboratory Techniq | 2020 |
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
Topics: Aged; Anticoagulants; Coronavirus Infections; COVID-19; Enoxaparin; Female; Fibrin Fibrinogen Degrad | 2020 |
Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial.
Topics: Anticoagulants; Betacoronavirus; Coronavirus Infections; COVID-19; Enoxaparin; Hemostasis; Humans; I | 2020 |
Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial".
Topics: Anticoagulants; Betacoronavirus; Coronavirus Infections; COVID-19; Enoxaparin; Humans; Pandemics; Pn | 2020 |
Cerebral Infarction in an Elderly Patient with Coronavirus Disease.
Topics: Aged, 80 and over; Anticoagulants; Aspirin; Betacoronavirus; Cerebral Infarction; Coronavirus; Coron | 2020 |
Pulmonary embolism: A complication of COVID 19 infection.
Topics: Adult; Aged; Anticoagulants; Betacoronavirus; Coronavirus Infections; COVID-19; Enoxaparin; Female; | 2020 |
Clinical experience with therapeutic dose of Low-Molecular-Weight Heparin.
Topics: Aged; Anti-Inflammatory Agents; Anticoagulants; Antihypertensive Agents; Azithromycin; Combined Moda | 2020 |
Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19.
Topics: Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Azithromycin; Betaco | 2020 |
Large artery ischemic stroke in severe COVID-19.
Topics: Aged; Brain Ischemia; Cerebral Arteries; Computed Tomography Angiography; Coronavirus Infections; CO | 2020 |
Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case Report.
Topics: Acute Disease; Aged; Anticoagulants; Betacoronavirus; Coronavirus Infections; COVID-19; Enoxaparin; | 2020 |
Covid-19: A systemic disease treated with a wide-ranging approach: A case report.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Azithromycin; China; Coronavirus Infecti | 2020 |
How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report.
Topics: Aged; Betacoronavirus; Blood Coagulation; Coronavirus Infections; COVID-19; Enoxaparin; Female; Fibr | 2020 |
Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban.
Topics: Arterial Occlusive Diseases; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatm | 2020 |
Venous thromboembolism in non-critically ill patients with COVID-19 infection.
Topics: Aged; Anticoagulants; Betacoronavirus; Coronavirus Infections; COVID-19; Enoxaparin; Female; Fondapa | 2020 |
VTE in ICU Patients With COVID-19.
Topics: Adult; Aged; Anticoagulants; Betacoronavirus; C-Reactive Protein; Computed Tomography Angiography; C | 2020 |
Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease.
Topics: Acute Disease; Aged; Anticoagulants; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Prog | 2020 |
A Case of 45-Year Man Who Succumbed to Coronavirus Disease 2019 (COVID-19).
Topics: Anti-Bacterial Agents; Anticoagulants; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus; | 2020 |
COVID-19 Pulmonary Infection with Pneumothorax in a Young Patient.
Topics: Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus; | 2020 |
A Rare Finding of Upper Limb Deep Venous Thrombosis in a Patient with COVID-19.
Topics: Anticoagulants; Arm; Aspirin; Betacoronavirus; Coronavirus Infections; COVID-19; Edema; Enoxaparin; | 2020 |
Use of awake proning to avoid invasive ventilation in a patient with severe COVID-19 pneumonitis.
Topics: Anticoagulants; Betacoronavirus; Chemoprevention; Computed Tomography Angiography; Coronavirus Infec | 2020 |
COVID-19 associated with extensive pulmonary arterial, intracardiac and peripheral arterial thrombosis.
Topics: Anticoagulants; Betacoronavirus; Clinical Deterioration; Computed Tomography Angiography; Coronaviru | 2020 |
COVID-19 patient with immune thrombocytopenic purpura.
Topics: Aged, 80 and over; Anticoagulants; Autoantibodies; Betacoronavirus; Combined Modality Therapy; Coron | 2020 |
An infection-oriented approach for thoracic endovascular aortic repair in a SARS-CoV-2 positive patient. A case report.
Topics: Anesthesia, Local; Antibiotic Prophylaxis; Anticoagulants; Antiviral Agents; Aortic Aneurysm, Thorac | 2020 |
Inferior mesenteric vein thrombosis and COVID-19.
Topics: Adult; Analgesics; Anticoagulants; Betacoronavirus; Coronavirus; Coronavirus Infections; COVID-19; E | 2020 |
Fondaparinux Use in Patients With COVID-19: A Preliminary Multicenter Real-World Experience.
Topics: Aged; Anticoagulants; Antithrombins; Coronavirus Infections; COVID-19; Enoxaparin; Factor Xa Inhibit | 2020 |
Venous thromboembolism and COVID-19: a case report and review of the literature.
Topics: Aged; Anticoagulants; Betacoronavirus; Computed Tomography Angiography; Coronavirus Infections; COVI | 2020 |
Treatment of COVID-19 induced chilblains with topical nitroglycerin.
Topics: Administration, Cutaneous; Anticoagulants; Betacoronavirus; Chilblains; Coronavirus Infections; COVI | 2020 |
The unusual experience of managing a severe COVID-19 case at home: what can we do and where do we go?
Topics: Adrenal Cortex Hormones; Ambulatory Care; Antiparasitic Agents; Betacoronavirus; Coronavirus Infecti | 2020 |
Severe COVID-19 infection associated with endothelial activation.
Topics: Aged; Antibodies, Antiphospholipid; Anticoagulants; Betacoronavirus; Blood Coagulation; Coronavirus | 2020 |
Severe COVID-19 infection associated with endothelial activation.
Topics: Aged; Antibodies, Antiphospholipid; Anticoagulants; Betacoronavirus; Blood Coagulation; Coronavirus | 2020 |
Severe COVID-19 infection associated with endothelial activation.
Topics: Aged; Antibodies, Antiphospholipid; Anticoagulants; Betacoronavirus; Blood Coagulation; Coronavirus | 2020 |
Severe COVID-19 infection associated with endothelial activation.
Topics: Aged; Antibodies, Antiphospholipid; Anticoagulants; Betacoronavirus; Blood Coagulation; Coronavirus | 2020 |
Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Betacoronavirus; Coronavirus Infections; COVID-19; C | 2020 |